FDA Nominee Crawford Still In Limbo; Grassley Wants More Answers
This article was originally published in The Gray Sheet
Executive Summary
Senate Finance Committee Chairman Charles Grassley (R-Iowa) is not satisfied with FDA commissioner-nominee Lester Crawford's answers to written questions posed as part of the confirmation process
You may also be interested in...
Grassley Requests FDA Info On Guidant ICD Alerts Following NEJM Article
Senate Finance Committee Chair Chuck Grassley (R-Iowa) is asking FDA for a detailed briefing on the "regulatory history" of Guidant's Ventak Prizm 2 DR ICD and the agency's plans to address medical device safety issues
Grassley Requests FDA Info On Guidant ICD Alerts Following NEJM Article
Senate Finance Committee Chair Chuck Grassley (R-Iowa) is asking FDA for a detailed briefing on the "regulatory history" of Guidant's Ventak Prizm 2 DR ICD and the agency's plans to address medical device safety issues
FDA Confirmation Process Hits A Roadblock: Time For Plan B?
Acting FDA Commissioner Lester Crawford's prospects for Senate confirmation may be jeopardized by the Health Committee's purported concern with a conduct allegation lodged against the nominee